These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23352934)

  • 1. Re: letter to the editor on "Alemtuzumab induction in renal transplantation: a meta-analysis and systemic review".
    Zhang X; Wang L
    Transpl Immunol; 2013 Mar; 28(2-3):72. PubMed ID: 23352934
    [No Abstract]   [Full Text] [Related]  

  • 2. Alemtuzumab induction therapy in kidney transplantation: a systematic review and meta-analysis.
    Morgan RD; O'Callaghan JM; Knight SR; Morris PJ
    Transplantation; 2012 Jun; 93(12):1179-88. PubMed ID: 22660659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alemtuzumab induction in pediatric kidney transplantation.
    Nguyen C; Shapiro R
    Pediatr Transplant; 2013 Jun; 17(4):319-20. PubMed ID: 23581963
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety and Efficacy of Alemtuzumab Induction in Highly Sensitized Pediatric Renal Transplant Recipients.
    Kim IK; Choi J; Vo AA; Kang A; Patel M; Toyoda M; Mirocha J; Kamil ES; Cohen JL; Louie S; Galera O; Jordan SC; Puliyanda DP
    Transplantation; 2017 Apr; 101(4):883-889. PubMed ID: 27495773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alemtuzumab induction therapy in kidney transplantation.
    Dhaun N; Kluth DC
    Lancet; 2015 Feb; 385(9970):770. PubMed ID: 25752171
    [No Abstract]   [Full Text] [Related]  

  • 6. Alemtuzumab induction therapy in kidney transplantation.
    Kuypers DR
    Lancet; 2014 Nov; 384(9955):1649-51. PubMed ID: 25078307
    [No Abstract]   [Full Text] [Related]  

  • 7. Alemtuzumab induction therapy in kidney transplantation.
    Berghofen A; Singer T; Krüger B; Krämer BK; Benck U
    Lancet; 2015 Feb; 385(9970):770-1. PubMed ID: 25752170
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction therapy in renal transplant recipients: how convincing is the current evidence?
    Wagner SJ; Brennan DC
    Drugs; 2012 Mar; 72(5):671-83. PubMed ID: 22439670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alemtuzumab induction therapy in kidney transplantation - Authors' reply.
    Haynes R; Baigent C; Landray MJ; Harden P; Friend P
    Lancet; 2015 Feb; 385(9970):771. PubMed ID: 25752173
    [No Abstract]   [Full Text] [Related]  

  • 10. Depleting antibody induction in simultaneous pancreas-kidney transplantation: a prospective single-center comparison of alemtuzumab versus rabbit anti-thymocyte globulin.
    Stratta RJ; Rogers J; Orlando G; Farooq U; Al-Shraideh Y; Doares W; Kaczmorski S; Farney AC
    Expert Opin Biol Ther; 2014 Dec; 14(12):1723-30. PubMed ID: 25156622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.
    Hill P; Cross NB; Barnett AN; Palmer SC; Webster AC
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004759. PubMed ID: 28073178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cam-path forward.
    Kirk AD
    Am J Transplant; 2013 Jan; 13(1):9-10. PubMed ID: 23167297
    [No Abstract]   [Full Text] [Related]  

  • 13. Transplantation: Alemtuzumab induction reduces acute rejection risk.
    Sidaway P
    Nat Rev Nephrol; 2014 Oct; 10(10):542. PubMed ID: 25112441
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduced-Intensity Conditioning Combined with (188)Rhenium Radioimmunotherapy before Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia: The Role of In Vivo T Cell Depletion.
    Schneider S; Strumpf A; Schetelig J; Wunderlich G; Ehninger G; Kotzerke J; Bornhäuser M
    Biol Blood Marrow Transplant; 2015 Oct; 21(10):1754-60. PubMed ID: 26001695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alemtuzumab pre-conditioning with tacrolimus monotherapy in pediatric renal transplantation.
    Shapiro R; Ellis D; Tan HP; Moritz ML; Basu A; Vats AN; Kayler LK; Erkan E; McFeaters CG; James G; Grosso MJ; Zeevi A; Gray EA; Marcos A; Starzl TE
    Am J Transplant; 2007 Dec; 7(12):2736-8. PubMed ID: 17908272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alemtuzumab induction in renal transplantation: a meta-analysis and systemic review.
    Zhang X; Huang H; Han S; Fu S; Wang L
    Transpl Immunol; 2012 Oct; 27(2-3):63-8. PubMed ID: 22960043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alemtuzumab induction in pediatric kidney transplantation.
    Kaabak MM; Babenko NN; Samsonov DV; Sandrikov VA; Maschan AA; Zokoev AK
    Pediatr Transplant; 2013 Mar; 17(2):168-78. PubMed ID: 23442101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic reviews of alemtuzumab in renal transplantation.
    O'Callaghan JM; Morgan RD; Knight SR; Morris PJ
    Transpl Immunol; 2013 Mar; 28(2-3):71. PubMed ID: 23352935
    [No Abstract]   [Full Text] [Related]  

  • 19. Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial.
    ; Haynes R; Harden P; Judge P; Blackwell L; Emberson J; Landray MJ; Baigent C; Friend PJ
    Lancet; 2014 Nov; 384(9955):1684-90. PubMed ID: 25078310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of induction therapy with alemtuzumab in kidney transplantation: a meta-analysis.
    Shou ZF; Zhou Q; Cai JR; Cheng J; He Q; Wu JY; Chen JH
    Chin Med J (Engl); 2009 Jul; 122(14):1692-8. PubMed ID: 19719973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.